US stock return on invested capital analysis and economic value added calculations to identify truly exceptional businesses. Our quality metrics help you find companies that generate superior returns on capital employed.
As of 2026-04-08, Keros Therapeutics Inc. (KROS) is trading at a current price of $12.5, marking a 2.12% gain on the day. This analysis examines key technical levels, recent market context, and potential future scenarios for the biotech stock, with no recent earnings data available for the company as of this publication. KROS has seen relatively range-bound trading in recent weeks, with price action largely tied to broader biotech sector flows rather than company-specific news. Key takeaways for
Is Keros Therapeutics (KROS) Stock heavily shorted | Price at $12.50, Up 2.12% - Analyst Recommended Stocks
KROS - Stock Analysis
4545 Comments
848 Likes
1
Emarosa
Community Member
2 hours ago
This feels like something I’ll regret later.
👍 286
Reply
2
Ceron
Active Contributor
5 hours ago
The passion here is contagious.
👍 92
Reply
3
Alcindor
Trusted Reader
1 day ago
I understood just enough to panic.
👍 158
Reply
4
Karslyn
Community Member
1 day ago
A slight profit-taking session may occur after recent gains.
👍 173
Reply
5
Veneshia
Regular Reader
2 days ago
Anyone else following this closely?
👍 159
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.